Loading...
A multicenter study of body mass index in cancer patients treated with anti-PD-1/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable
BACKGROUND: Recent evidence suggested a potential correlation between overweight and the efficacy of immune checkpoint inhibitors (ICIs) in cancer patients. PATIENTS AND METHODS: We conducted a retrospective study of advanced cancer patients consecutively treated with anti-PD-1/PD-L1 inhibitors, in...
Saved in:
Published in: | J Immunother Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
BioMed Central
2019
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6391761/ https://ncbi.nlm.nih.gov/pubmed/30813970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0527-y |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|